The neoepitope IGPRALDVL, which elicited intermediate tumor rejection (Figure 2A) and a good tetramer CD8+ T cell response in naive mice (Figure 2F), elicited significant CD8+ T cell response in tumor-bearing mice as well (Figure 2F). The gene discussed is CD8A; the disease is neoplasm.